Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6167298 | Urology | 2013 | 9 Pages |
Abstract
PVP and HOLAP seem to be equally effective and safe, with similar long-term outcome data, including cost. Regardless the laser wavelength, at least 1 of 5 patients will need retreatment. BNC is a more prevalent cause of early retreatment in smaller glands with both lasers. Postoperative prostate-specific antigen reduction of less than 20% warrants careful follow-up for recurrent symptoms secondary to residual prostate tissue.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ahmed M. Elshal, Hazem M. Elmansy, Mostafa M. Elhilali,